European Pharma and Biotech: Benchmarking Quality, Compliance and Resilience in 2025
The European life sciences sector is undergoing major change as regulatory, digital, and sustainability pressures rise. This NSF commissioned research report compiled by Opinium, reveals how pharma and biotech leaders are responding and how they measure up against their peers.
To help leaders understand how prepared the sector truly is, NSF partnered with Opinium Research to capture insights from 100 senior executives across pharmaceutical and biotechnology organizations. The findings provide a clear benchmark of quality maturity, data integrity, inspection readiness, and cultural resilience across the region.
What you’ll learn
Download this NSF and Opinium research report to:
- Benchmark your organization’s performance against peers across Europe and the UK in quality maturity, data integrity, and inspection readiness and more.
- Expose hidden risks in supply chains, data systems, and workforce capability.
- See where leaders invest in digital QMS, AI-driven analytics, sustainability, and skills development.
- Strengthen resilience through smarter systems, stronger culture, and sharper compliance strategies.
- Hear from NSF experts Dr Kay Hukin and Dr Peter Gough on turning compliance into competitive advantage.
Download the full report today to benchmark your performance, uncover actionable insights, and prepare your organization for the next era of quality and resilience.
Download NSF’s full research report
How NSF Can Help You
